A carregar...
Comparison of the effects of the PI3K/mTOR inhibitors NVP-BEZ235 and GSK2126458 on tamoxifen-resistant breast cancer cells
BACKGROUND: Treatment with anti-estrogens or aromatase inhibitors is commonly used for patients with estrogen receptor-positive (ER(+)) breast cancers; however resistant disease develops almost inevitably, requiring a choice of secondary therapy. One possibility is to use inhibitors of the PI3K/mTOR...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Landes Bioscience
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3127046/ https://ncbi.nlm.nih.gov/pubmed/21464613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.11.11.15527 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|